Bladder cancer
114 results
1 - 100
Neo‐adjuvant chemotherapy for invasive bladder cancer- Surgery versus radiotherapy for muscle invasive bladder cancer
- Intravesical Bacillus Calmette‐Guérin in Ta and T1 bladder cancer
- Adjuvant chemotherapy for invasive bladder cancer (individual patient data)
- Neoadjuvant cisplatin for advanced bladder cancer: Cochrane systematic review
- Perioperative nutrition for the treatment of bladder cancer by radical cystectomy
- Intravesical Bacillus Calmette‐Guérin versus epirubicin for Ta and T1 bladder cancer
- Blue versus white light for transurethral resection of non‐muscle invasive bladder cancer
- Intravesical gemcitabine for non‐muscle invasive bladder cancer
- Gemcitabine for unresectable, locally advanced or metastatic bladder cancer: Cochrane systematic review
- Intravesical electromotive drug administration for non‐muscle invasive bladder cancer
- Intravesical Bacillus Calmette‐Guérin versus mitomycin C for Ta and T1 bladder cancer
- En‐bloc resection versus conventional transurethral resection for patients with non‐muscle‐invasive bladder cancer
- Robotic versus open radical cystectomy for bladder cancer in adults
- Postoperative interventions for preventing bladder dysfunction after radical hysterectomy in women with early‐stage cervical cancer
- Narrow band imaging versus white light cystoscopy alone for transurethral resection of non‐muscle invasive bladder cancer
- Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Cochrane systematic review
- Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer
- Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy
- Single‐dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma
- Immunotherapy for advanced or metastatic urothelial carcinoma
- Nerve‐sparing radical hysterectomy compared to standard radical hysterectomy for women with early stage cervical cancer (stage Ia2 to IIa)
- Hypofractionation for clinically localized prostate cancer
- Non‐surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis
- Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy
- Adjuvant radiotherapy following radical prostatectomy for prostate cancer
- Simple hysterectomy with pelvic lymphadenectomy versus radical hysterectomy with pelvic lymphadenectomy for women with stage IA2‐IB1 cervical cancer
- Effects of exposure to night shift work on cancer risk in workers
- Chemoradiation for advanced primary vulval cancer
- Retzius‐sparing versus standard robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer.
- Surgical treatment of stage IA2 cervical cancer
- Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers
- Cholecystectomy for patients with silent gallstones
- Hyperbaric oxygenation for tumour sensitisation to radiotherapy
- Dose‐escalated radiotherapy for clinically localized and locally advanced prostate cancer
- Exenterative surgery for recurrent gynaecological malignancies
- Retroperitoneal drainage versus no drainage after pelvic lymphadenectomy for the prevention of lymphocyst formation in women with gynaecological malignancies
- Terazosin for benign prostatic hyperplasia: Cochrane systematic review
- Tamsulosin for benign prostatic hyperplasia: Cochrane systematic review
- Drugs for treating urinary schistosomiasis
- Conservative management for postprostatectomy urinary incontinence
- Selenium for preventing cancer
- Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review
- Surgical management for upper urinary tract transitional cell carcinoma: Cochrane systematic review
- Screening with urinary dipsticks for reducing morbidity and mortality
- Platinum‐containing regimens for triple‐negative metastatic breast cancer
- Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer
- Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer
- Posterior musculofascial reconstruction in robotic‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer
- Platinum‐containing regimens for metastatic breast cancer
- High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer
- Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy: Cochrane systematic review
- Laparoscopic versus open total mesorectal excision for rectal cancer
- Laparoscopy versus laparotomy for the management of early stage endometrial cancer
- Spinal cord stimulation for cancer‐related pain in adults
- Hyperbaric oxygen therapy for late radiation tissue injury